221 related articles for article (PubMed ID: 38667326)
1. Genomic Engineering of Oral Keratinocytes to Establish In Vitro Oral Potentially Malignant Disease Models as a Platform for Treatment Investigation.
Wils LJ; Buijze M; Stigter-van Walsum M; Brink A; van Kempen BE; Peferoen L; Brouns ER; de Visscher JGAM; van der Meij EH; Bloemena E; Poell JB; Brakenhoff RH
Cells; 2024 Apr; 13(8):. PubMed ID: 38667326
[TBL] [Abstract][Full Text] [Related]
2. Expression of p16 in oral cancer and premalignant lesions.
Buajeeb W; Poomsawat S; Punyasingh J; Sanguansin S
J Oral Pathol Med; 2009 Jan; 38(1):104-8. PubMed ID: 19192055
[TBL] [Abstract][Full Text] [Related]
3. Molecular changes associated with oral dysplasia progression and acquisition of immortality: potential for its reversal by 5-azacytidine.
McGregor F; Muntoni A; Fleming J; Brown J; Felix DH; MacDonald DG; Parkinson EK; Harrison PR
Cancer Res; 2002 Aug; 62(16):4757-66. PubMed ID: 12183435
[TBL] [Abstract][Full Text] [Related]
4. Oral lichen planus has a high rate of TP53 mutations. A study of oral mucosa in icelanD.
Ogmundsdóttir HM; Hilmarsdóttir H; Astvaldsdóttir A; Jóhannsson JH; Holbrook WP
Eur J Oral Sci; 2002 Jun; 110(3):192-8. PubMed ID: 12120703
[TBL] [Abstract][Full Text] [Related]
5. [Precancers of the oral mucosa: clinic, diagnostics].
Rabinovich OF; Rabinovich IM; Babichenko II; Umarova KV; Bekmurzova LF
Stomatologiia (Mosk); 2024; 103(2):5-11. PubMed ID: 38741528
[TBL] [Abstract][Full Text] [Related]
6. Role of bcl-2 oncoprotein in oral potentially malignant disorders and squamous cell carcinoma: an immunohistochemical study.
Sudha VM; Hemavathy S
Indian J Dent Res; 2011; 22(4):520-5. PubMed ID: 22124045
[TBL] [Abstract][Full Text] [Related]
7. [Detection of TP53-mutations in brush biopsies from oral leukoplakias].
Scheifele C; Schlechte H; Bethke G; Reichart PA
Mund Kiefer Gesichtschir; 2002 Nov; 6(6):410-4. PubMed ID: 12447653
[TBL] [Abstract][Full Text] [Related]
8. High frequency of hypermethylation of p14, p15 and p16 in oral pre-cancerous lesions associated with betel-quid chewing in Sri Lanka.
Takeshima M; Saitoh M; Kusano K; Nagayasu H; Kurashige Y; Malsantha M; Arakawa T; Takuma T; Chiba I; Kaku T; Shibata T; Abiko Y
J Oral Pathol Med; 2008 Sep; 37(8):475-9. PubMed ID: 18284544
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
11. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of p53, p16 and hTERT in oral squamous cell carcinoma and potentially malignant disorders.
Abrahao AC; Bonelli BV; Nunes FD; Dias EP; Cabral MG
Braz Oral Res; 2011; 25(1):34-41. PubMed ID: 21359449
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
14. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma.
Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958
[TBL] [Abstract][Full Text] [Related]
15. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
17. Potentially Malignant Oral Disorders and Cancer Transformation.
Ganesh D; Sreenivasan P; Öhman J; Wallström M; Braz-Silva PH; Giglio D; Kjeller G; Hasséus B
Anticancer Res; 2018 Jun; 38(6):3223-3229. PubMed ID: 29848669
[TBL] [Abstract][Full Text] [Related]
18. Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.
Shahnavaz SA; Bradley G; Regezi JA; Thakker N; Gao L; Hogg D; Jordan RC
Cancer Res; 2001 Mar; 61(6):2371-5. PubMed ID: 11289098
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Implications of DNA Repair, Ploidy and Telomerase in the Malignant Transformation Risk Assessment of Leukoplakia.
Thomas G; Tr S; George S P; Somanathan T; Sarojam S; Krishnankutti N; Sreedharan H; Ankathil R
Asian Pac J Cancer Prev; 2020 Feb; 21(2):309-316. PubMed ID: 32102504
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]